Uğur ÇELİK, Engin Bilge ÖZGÜRHAN, Umut HERDEM, Ahmet DEMİROK, Ahmet Taylan YAZICI, Cengiz ALAGÖZ, Kemal YÜKSEL, Ökkeş BAZ

Diyabetik traksiyonel retina dekolmanlı olgularda 23-gauge pars plana vitrektomi cerrahisi sonuçları

Amaç: Diyabetik traksiyonel retina dekolman (TRD)'lı hastalara uygulanan pars plana vitrektomi (PPV) sonuçlarını ve komplikasyonlarını incelemek.Yöntemler: Diyabetik TRD'si bulunan 193 hastanın 210 gözü çalışmaya dahil edildi. TRD nedeniyle 23-Gauge (G) PPV yapılan hastalarımızın dosyaları geriye dönük olarak incelendi. Tüm hastaların preoperatif ve postoperatif görme keskinliği (GK), göz-içi basınç (GİB)'ları, biyomikroskopik muayeneleri, indirekt oftalmoskopla fundus muayeneleri, intraoperatif ve postoperatif komplikasyonları, intraoperatif endotamponad kullanımı, postoperatif dönemde geçirdikleri ameliyatlar kaydedildi.Bulgular: Çalışmaya alınan 193 hastanın 95'i erkek (%49,2), 98'i kadın (%50,8) olup cerrahi sırasındaki yaş ortalamaları 56,01 ±10,91 yıl idi. Hasta grubumuzun ortalama postoperatif takip süresi 18,47 ±14,06 ay idi. 97 göze preoperatif intravitreal (İV) bevacizumab enjeksiyonu yapıldı. Hastaların preoperatif GK'leri ile postoperatif 1.,3.,6,12.,24.,36. ay ve son kontrollerdeki GK'leri karşılaştırıldığında istatistiksel olarak anlamlı bir artış görüldü (p

23-gauge pars plana vitrectomy surgery results of the cases with diabetic tractional retinal detachment

Objective: To evaluate the pars plana vitrectomy (PPV) surgery results of the patients with diabetic tractional retinal detachment (TRD).Methods: Two hundred ten eyes of 193 patients with diabetic TRD were enrolled to the study. Patients with TRD underwent 23-Gauge(G) PPV were reviewed retrospectively. All patients' preoperative and postoperative visual acuity changes, intraocular pressure changes, biomicroscopy, indirect ophthalmoscopy fundus examination, intraoperative and postoperative complications, intraoperative use of tamponade and postoperative period surgical notes were evaluated.Results: Ninety-five males (49.2%), 98 female (50.8%) of 193 patients were included to the study. Mean age was 56.01 ± 10.91 years during the surgery. The average postoperative follow-up period was 18.47 ± 14.06 months. Ninety-seven eyes were performed preoperative intravitreal (IV) bevacizumab injection. Statistically significant increase in the final visual acuity compared to the controls were recorded at 1, 3, 6, 12, 24, 36. months. (p

PDF

___

Kakehashi A: Total en bloc excision:A modified vicrec- tomy technigue for proliferative diabetic retinopathy. Am J Ophtalmol 2002;134:763-765.
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
Fine SL, Patz A. Ten years after the Diabetic Retinopa- thy Study. Ophthalmology 1987;94:739-740.
Meredith T.A, Kaplan H.J, Aaberg T.M. Pars plana vitrectomy techniques for relief of epiretinal trac- tion by membrane segmentation.Am J Ophtalmol 1980;89:408-413.
Brourman ND, Blumenkranz MS, Cox MS, Trese MT. Silicone oil for the treatment of severe proliferative di- abetic retinopathy. Ophthalmology 1989;96:759-764.
Flynn Jr HW, Chew EY, Simons BD, et al. Pars plana vitrectomy in the Early Treatment Diabetic Retinopa- thy Study ETDRS report number 17. Ophthalmology 1992;99:1351-1357.
Williams DF, Williams GA, Hartz A, et al. Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology 1989;96:752-758.
Hernandez-Da Mota SE, Nunez-Solorio SM. Experi- ence with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy. Eur J Ophthalmol 2010;20:1047- 1052.
Aaberg T.M, Abrams G.W. Changing indications and techniques for vitrectomy in management of com- plications of diabetic retinopathy. Ophthalmology 1987;94:775-779.
Ratner CM, Michels RG, Auer C, Rice TA. Pars plana vitrectomy for complicated retinal detachments. Oph- thalmology. 1983;90:1323-1327.
Meier P, Wiedemann P. Vitrectomy for tractional mac- ular detachment in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997;235:569-574.
Kır N. Diabetik retinopatide pars plana vitrektomi sonuçları. T Oft Gaz 2001;31:638-643.
Kangas TA, Bennett SR, Flynn HW Jr, et al. Revers- ible loss of light perception after vitreoretinal surgery. Am J Ophthalmol 1995;120:751-756.
Blankenship G, Cortez R, Machemer R. The lens and pars plana vitrectomy for diabetic retinopathy compli- cations. Arch Ophthalmol 1979;97:1263-1267.
Rice TA, Michels RG, Maguire MG, Rice EF. The ef- fect of lensectomy on the incidence of iris neovascu- larization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983;95:1- 11.
Braunstein RE, Airiani S. Cataract surgery results after pars plana vitrectomy. Curr Opin Ophthalmol 2003;14:150-154.
Biro Z, Kovacs B. Results of cataract surgery in pre- viously vitrectomized eyes. J Cataract Refract Surg 2002;28:1003-1006.
Michels RG. Vitreous surgery for macular pucker. Am J Ophthalmol 1981;92:628-369.
Williams DF, Williams GA, Hartz A, et al. Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology 1989;96:752-758.
La Heij EC, Tecim S, Kessels AG, et al. Clinical vari- ables and their relation to visual outcome after vitrec- tomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 2004;242:210-217.
Schachat AP, Oyakawa RT, Michels RG, Rice T.A. Complications of vitreous surgery for diabetic retinop- athy. II. Postoperative complications. Ophthalmology 1983;90:522-530.